Literature DB >> 18407301

Defective emotion recognition in early HD is neuropsychologically and anatomically generic.

Susie M D Henley1, Edward J Wild, Nicola Z Hobbs, Jason D Warren, Chris Frost, Rachael I Scahill, Gerard R Ridgway, David G MacManus, Roger A Barker, Nick C Fox, Sarah J Tabrizi.   

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder that classically presents with motor, cognitive and psychiatric symptoms. However, other abnormalities also occur in this condition, notably deficient recognition of facial emotional expressions. Deficits in emotion recognition impact significantly on the lives of HD patients and their families and thus it is important to clarify the onset and pattern of impairment. This study investigated facial emotion recognition in a large cohort of early HD patients, and premanifest gene-carriers. We used voxel-based morphometry (VBM) to examine the neuroanatomical correlates of emotion recognition performance. Forty patients with early HD, 21 premanifest gene carriers and 20 controls were assessed using 24 faces from the Ekman Pictures of Facial Affect, and volumetric brain MRI. The HD group was significantly worse than controls at recognising, surprise, disgust, anger and fear, and worse than the premanifest group at recognising disgust and anger. When patient data were expressed as z-scores, recognition of anger was significantly worse than disgust in the early HD group. In the VBM analysis, these deficits were associated with common regional atrophy: impaired recognition of surprise, disgust, anger and fear were all associated with striatal volume loss. Fear was associated with additional atrophy of the right insula and left and right lateral orbitofrontal cortex. Even in early HD there is a wide-ranging impairment in recognition of negative emotions denoting 'threat'. Our findings implicate a generic fronto-subcortical network in the pathogenesis of these emotion recognition deficits.

Entities:  

Mesh:

Year:  2008        PMID: 18407301     DOI: 10.1016/j.neuropsychologia.2008.02.025

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  34 in total

1.  Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

Authors:  Paul G Unschuld; Suresh E Joel; James J Pekar; Sarah A Reading; Kenichi Oishi; Julie McEntee; Megan Shanahan; Arnold Bakker; Russell L Margolis; Susan S Bassett; Adam Rosenblatt; Susumu Mori; Peter C van Zijl; Christopher A Ross; Graham W Redgrave
Journal:  Psychiatry Res       Date:  2012-09-11       Impact factor: 3.222

2.  The structural correlates of functional deficits in early huntington's disease.

Authors:  Christine Delmaire; Eve M Dumas; Michael A Sharman; Simon J A van den Bogaard; Romain Valabregue; Céline Jauffret; Damian Justo; Ralf Reilmann; Julie C Stout; David Craufurd; Sarah J Tabrizi; Raymund A C Roos; Alexandra Durr; Stéphane Lehéricy
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

3.  Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.

Authors:  Charlotte Soneson; Magnus Fontes; Yongxia Zhou; Vladimir Denisov; Jane S Paulsen; Deniz Kirik; Asa Petersén
Journal:  Neurobiol Dis       Date:  2010-08-02       Impact factor: 5.996

4.  Through your eyes or mine? The neural correlates of mental state recognition in Huntington's disease.

Authors:  Clare M Eddy; Hugh E Rickards; Peter C Hansen
Journal:  Hum Brain Mapp       Date:  2017-12-17       Impact factor: 5.038

Review 5.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

6.  Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.

Authors:  Rachael I Scahill; Nicola Z Hobbs; Miranda J Say; Natalie Bechtel; Susie M D Henley; Harpreet Hyare; Douglas R Langbehn; Rebecca Jones; Blair R Leavitt; Raymund A C Roos; Alexandra Durr; Hans Johnson; Stéphane Lehéricy; David Craufurd; Christopher Kennard; Stephen L Hicks; Julie C Stout; Ralf Reilmann; Sarah J Tabrizi
Journal:  Hum Brain Mapp       Date:  2011-11-18       Impact factor: 5.038

7.  Neural correlates of impaired emotion processing in manifest Huntington's disease.

Authors:  Imis Dogan; Christian Saß; Shahram Mirzazade; Alexandra Kleiman; Cornelius J Werner; Anna Pohl; Johannes Schiefer; Ferdinand Binkofski; Jörg B Schulz; N Jon Shah; Kathrin Reetz
Journal:  Soc Cogn Affect Neurosci       Date:  2013-03-11       Impact factor: 3.436

8.  Theory of mind and empathy in preclinical and clinical Huntington's disease.

Authors:  Najia Adjeroud; Jérémy Besnard; Nicole El Massioui; Christophe Verny; Adriana Prudean; Clarisse Scherer; Bénédicte Gohier; Dominique Bonneau; Philippe Allain
Journal:  Soc Cogn Affect Neurosci       Date:  2015-07-25       Impact factor: 3.436

9.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Authors:  Sarah J Tabrizi; Douglas R Langbehn; Blair R Leavitt; Raymund Ac Roos; Alexandra Durr; David Craufurd; Christopher Kennard; Stephen L Hicks; Nick C Fox; Rachael I Scahill; Beth Borowsky; Allan J Tobin; H Diana Rosas; Hans Johnson; Ralf Reilmann; Bernhard Landwehrmeyer; Julie C Stout
Journal:  Lancet Neurol       Date:  2009-07-29       Impact factor: 44.182

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.